Home/Filings/4/0000875320-24-000078
4//SEC Filing

Sachdev Amit 4

Accession 0000875320-24-000078

CIK 0000875320other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:38 PM ET

Size

8.8 KB

Accession

0000875320-24-000078

Insider Transaction Report

Form 4
Period: 2024-02-16
Sachdev Amit
EVP Chief Patient & Ext Af Off
Transactions
  • Tax Payment

    Common Stock

    2024-02-20$420.58/sh2,623$1,103,18168,243 total
  • Sale

    Common Stock

    2024-02-20$420.79/sh4,254$1,790,04163,989 total
  • Tax Payment

    Common Stock

    2024-02-16$424.01/sh3,498$1,483,18770,866 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    882
  • Common Stock

    (indirect: By Trust)
    6,565
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001406338

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:38 PM ET
Size
8.8 KB